
Today's story
Legend Biotech names Novartis executive Ingrid Zhang CEO
Legend Biotech appointed Ingrid Zhang as Chief Executive Officer, effective September 15, 2026, with interim CEO Alan Bash becoming President of CARVYKTI. Zhang, a former Novartis executive and China head, brings broad global leadership experience from AstraZeneca, Pfizer, and McKinsey as the board positions Legend for its next growth phase.
Business · 10 sources · Sep 15, 2026Read itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About LEGEND
Legend are an Icelandic alternative rock/electronic band from Reykjavík.
Everything about LEGEND →